Acetylcholine (ACh) regulates vital functions of T cells by acting on the nicotinic and muscarinic classes of cholinergic receptors, nAChR and mAChRs, respectively. This study was performed in murine splenic T cells. In freshly isolated CD4 and CD8 T cells, we detected mRNAs encoding a5, a9, a10, b1, b2, b4 nAChR subunits and M 1 , M 3 , M 4 and M 5 mAChR subtypes, whereas a2 was detected only in CD8 T cells. In vitro activation of CD4 T cells through T-cell receptor (TCR)/CD3 cross-linking was associated with the appearance of a4 and a7, upregulation of a5, a10, b4, M 1 and M 5 and downregulation of a9 and b2, whereas in vitro activation of CD8 T cells also featured the appearance of a4 and a7, as well as upregulation of a2, a5, b4, M 1 and M 4 , and downregulation of a10, b1, b2 and M 3 . In vitro polarization toward T helper (Th) 1 lineage was associated with a decrease of b2, b4 and M 3 expression; that toward Th2 cells with downregulation of a9 and M 3 , and upregulation of M 1 and M 5 ; and that toward Th17 phenotype with downregulation of a9, a10, b2 and M 3 mAChR. Polarized T cells also expressed a4, but not a1, a2, a3, a6, b3 or M 2 . To determine the role of cholinergic receptors in mediating the immunoregulatory action of autocrine/paracrine ACh, we analyzed the effects of nicotinic and muscarinic agonists ± antagonists on cytokine production in the CD4 þ CD62L þ T cells co-stimulated via TCR/CD3 cross-linking. The nicotinergic stimulation upregulated interferon-g (IFN-g) and downregulated interleukin (IL)-17 secretion, whereas the muscarinic stimulation enhanced IL-10 and IL-17 and inhibited INF-g secretion. These results demonstrated plasticity of the T-cell cholinergic system.
Introduction
Recent research indicates that acetylcholine (ACh) acts as an autocrine/paracrine immunomodulator. 1, 2 Its role in the development of T cells and generation of specific T-cell repertoire is being intensively studied. Human lymphocytes express cholinergic receptors and enzymes that constitute an independent non-neuronal cholinergic system, or ACh axis, that can either upregulate or downregulate the immune response. [3] [4] [5] [6] It has been demonstrated that the immunological activation of lymphocytes evokes cholinergic signal transmission between T cells and target cells by enhancing synthesis and release of ACh and modifying the expression of ACh receptors (reviewed in ref. 2) . T cells produce more ACh than B cells, and CD4 cells more than CD8 cells. 7, 8 T cells contain 0.36 pmol of ACh per 10 6 cells. 9 Upon interaction with antigen-presenting cells via T-cell receptor (TCR)/ CD3, T cells show enhanced synthesis and release of ACh. 2 ACh and related compounds elicit biological effects through binding to the nicotinic and muscarinic classes of ACh receptors, nAChRs and mAChRs. The reported effects vary a great deal, and sometimes are diametrically opposite (reviewed in ref. 10 ). The complete repertoire of the ACh receptors in T-cell populations in mice and their exact role in T-cell development and differentiation remain to be elucidated.
The nAChRs are classic representatives of the superfamily of ligand-gated ion channel proteins, or ionotropic receptors, mediating the influx of Na þ and Ca 2 þ , and efflux of K þ . 11 Myocytes express a1, b1, g, d, and e subunits. In other cells, 12 'neuronal' nAChR subunit genes encoding a pentameric protein have been identified and designated a2-a10 and b2-b4. [12] [13] [14] [15] Each subunit has four putative transmembrane-spanning domains and a similar topological structure. The a7 and a9 subunits are capable of forming homomeric nAChR channels, which are a-bungarotoxin sensitive. The heteromeric channels can be composed of a2, a3, a4, a5, a6, b2, b3 and b4 subunits, for example, a3(b2/b4)±a5 and also a9 can form a heteromeric channel with a10. 15 The mAChRs are single-subunit transmembrane glycoproteins that mediate the metabolic response to ACh through the interactions of G proteins with signal transducing enzymes, leading to increases or decreases in second messengers, ion concentrations and modulations of protein kinase activities. The mAChR family is comprised of five, M 1 -M 5 , G protein-coupled receptor subtypes. 16, 17 Notably, the outcome of nicotinic or muscarinic receptor activation can be contradictory, because individual members of each class of ACh receptors differ in their ligand-binding affinities and downstream effectors (reviewed in ref. [18] [19] [20] . Furthermore, the repertoire of ACh receptors expressed in non-neuronal cells changes during cell development, leading to reciprocal changes in the cellular functions controlled by autocrine/paracrine ACh (reviewed in ref. 21) .
The purpose of the present study was to integrate information about the structure and activity of the ACh regulatory axis with the phenotypic and functional alterations of murine T cells during their development and commitment. We hypothesized that, by analogy with other types of non-neuronal cells, the phenotype and biological functions of ACh receptors in T cells change upon cell activation and differentaition. In this study, we identified subtypes of nAChRs and mAChRs expressed in freshly isolated murine splenic CD4 and CD8 T cells before and after their activation via TCR/CD3 crosslinking, characterized changes in the repertoire of ACh receptors during the CD4 þ CD62L þ T cell in vitro differentiation toward the T helper (Th) 1, Th2 and Th17 lineages, and demonstrated that the nicotinergic stimulation facilitates Th1 and inhibits Th17 differentiation, whereas the muscarinic signals facilitate Th2 and Th17 differentiation. Elucidation of the structure and function of ACh receptors in distinct murine T-cell subpopulations helps elucidate the mechanism diversifying the effect of autocrine/paracrine ACh to allow selective regulation of specific T-cell subsets. Learning the cholinergic pharmacology of T-cell differentiation and function should allow new strategies to control immune response by selectively activating or blocking the ACh receptor subtypes involved in a particular step of T-cell development.
Results

Differential expression of ACh receptors in murine T-cell populations
In freshly isolated murine CD4 and CD8 T lymphocytes, we detected mRNAs encoding a5, a9, a10, b1, b2 and b4 nAChR subunits, and M 1 , M 3 , M 4 and M 5 mAChR subtypes, whereas a2 mRNA was detected only in CD8 T cells (Table 1) . The assays revealed variations in the level of expression of a5, a9, a10, b1, b2, b4, M 1 , M 3 , M 4 and M 5 between CD4 and CD8 T cells. To further characterize the differences, we expressed results as the relative mRNA level of each receptor in CD8 vs that in CD4 T cells. The statistically significant differences (Po0.05) were found for a5, a10, b4 and M 4 , whose expression levels in CD4 T cells exceeded that in CD8 T cells, as well as for b1 that was expressed at a higher level in CD8 T cells (Figure 1 ).
These findings demonstrated that CD4 and CD8 T cells express distinct repertoires of ACh receptors, which indicated that each major T-cell population can respond to ACh and cholinergic drugs in a unique fashion.
The TCR stimulation alters expression of ACh receptors in CD4 and CD8 cells To determine whether functional activation of major murine T-cell populations alters their ACh receptor profile, we analyzed both freshly isolated T cells and T cells stimulated by TCR cross-linking with CD3 and CD28 antibodies for 5 days. Relative changes of receptor mRNAs and proteins were determined by quantitative PCR and in-cell western, respectively. The TCR stimulation altered repertoires of the cholinergic receptors in both T-cell populations at both mRNA and protein levels. Activation of CD4 T cells was associated with the appearance of a4, and a7, and significant (Po0.05) Activation of nAChRs facilitates T-cell differentiation into Th1 lineage Next, we evaluated the function of T-cell ACh receptors by measuring the effects of cholinergic stimulation on CD4 T-cell polarization. The CD4 þ CD62L þ T cell cultures were exposed to the ACh receptor class-specific cholinergic agonist ± antagonist for 5 days, followed by measurements of interferon-g (INF-g), interleukin (IL)-4, IL-10 and IL-17 in the supernatants. Exposure to the nAChR agonist nicotine given alone did not alter the cytokine production ( Figure 3 ). In marked contrast, pharmacological activation of nAChRs simultaneously with TCR/CD3 cross-linking significantly (Po0.05) upregulated INF-g production and downregulated IL-17 secretion ( Figure 3 ). These effects of nicotine were abolished in the presence of the nAChR antagonist mecamylamine (Po0.05), indicating that the observed changes in the cytokine production were receptor mediated.
These results indicated that nAChRs are coupled to Th1 polarization of CD4 T cells and inhibition of their differentiation toward Th17 lineage.
Activation of mAChRs facilitates T-cell differentiation toward Th2 and Th17 lineages
To identify the role of the muscarinic arm of the autocrine/paracrine ACh axis in T-cell development and differentiation, we exposed naïve CD4 þ CD62L þ T cells to the muscarinic agonist muscarine ( Figure 4 ). When given alone to unstimulated cells, muscarine did not induce any detectable changes in the cytokine production (P40.05). However, when the T cells were exposed to muscarine simultaneously with their activation via TCR/CD3 cross-linking, we observed statistically significant (Po0.05) enhancement of IL-10 and IL-17 production and inhibition of INF-g secretion (Po0.05). The effects of muscarine were blocked in the presence of the muscarinic antagonist atropine (Figure 4 ). These results suggested that ACh signaling through T-cell mAChRs facilitates the development Th2 and Th17 responses.
Differences of the profiles of ACh receptors among Th1, Th2 and Th17 CD4 T cells Having established that distinct T-cell populations express different repertoires of ACh receptors and that stimulation of naïve CD4 T cells through their nAChRs and mAChRs exhibit reciprocal effects on polarization of naïve CD4 þ CD62L þ T cells, we hypothesized that the ACh receptor profiles in Th1, Th2 and Th17 cells are different. To test this hypothesis, we measured changes in the relative amounts mRNA encoding each nAChR subunit and mAChR subtype in CD4 þ CD62L þ T cells before and after their polarization into the Th1, Th2 and Th17 lineages. The intact CD4 þ CD62L þ T cells expressed a5, a9, a10, b1 and b2 nAChR subunits, and M 1 , M 3 , M 4 and M 5 mAChR subtypes ( Figure 5 ). Polarization toward 
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Th1 cells was associated with significant (Po0.05) decrease of b2 (mRNA), b4 (mRNA) and M 3 (mRNA/ protein) expression; that toward the Th2 lineage with downregulation of a9 (mRNA) and M 3 (mRNA/protein), and upregulation of M 1 (mRNA/protein) and M 5 (mRNA/protein); and that toward Th17 phenotype with downregulation of a9 (mRNA/protein), a10 (mRNA), b2 (mRNA) and M 3 (mRNA/protein; Figure 5 ). All polarized T cells began to express a4, with Th2 cells featuring the highest amount of this nAChR ( Figure 5 ), but lacked a1, a2, a3, a6, b3 and M 2 receptors (data not shown). Thus, on the one hand, distinct cholinergic receptors exhibit differential control of T-cell polarization and, on the other hand, T-cell polarization is associated with acquisition of unique ACh receptor profile.
Discussion
In this study, we demonstrated for the first time that the expression patterns of nAChRs and mAChRs vary among major populations of murine splenic T lymphocytes, and identified the effects of TCR stimulation on the ACh receptor gene expression in CD4 and CD8 cells. We also demonstrated that while activation of nAChRs in naïve CD4 cells favors their differentiation toward the Th1 lineage and inhibits Th17 polarization, the muscarinic stimulation fosters development of Th2 and Th17 cells but inhibits Th1 polarization. These findings illustrate plasticity of the T-cell cholinergic system and suggest that autocrine/paracrine ACh has an important role in the physiological control of T-cell development and function.
There is a large body of evidence that ACh regulates vital functions of T cells. The immunosuppressive/antiinflammatory function of a7 nAChR is well established. The signaling downstream of a7 nAChR on T cells controls inflammatory responses and a7 À/À -derived T cells were unaffected by nicotine. 22 We have previously demonstrated that upon immunization with ovalbumin, the a7 nAChR knockout mice develop increased serum level of antigen-specific IgG 1 . 23 In marked contrast, immunized M 1 /M 5 mAChR knockout mice show diminished antigen-specific IgG 1 production. 24 The reported pro-inflammatory/immunostimulatory effects of nicotine include increased secretion of IL-12 by Th1 T cells, 25 enhanced Con A-induced production of IFN-g 26 and protection of lymphocytes from cortisol-induced apoptosis. 27 It has been proposed that the nicotinergic pro-inflammatory cascade is mediated by a9 nAChR. 28 The immunoregulatory effects of ACh may differ depending on the repertoire of cholinergic receptors expressed by a T cell, because different ACh receptor types couple distinct signaling pathway leading to unique changes in cell state and function (reviewed in ref. 21 ). In the past, the changes in the pattern of expression of mouse nAChR subunits during T-cell development and differentiation were suggested by Figure 3 The nicotinic effects on cytokine production by CD4 þ CD62L þ T cells. The enriched naïve CD4 þ CD62L þ T cells were cultured without any additions (control) or stimulated with anti-CD3 and anti-CD28 in the presence or absence of the nAChR agonist nicotine, 1 mM, ± the antagonist mecamylamine, 100 mM, as detailed in Materials and methods. After 5 days in the culture, the supernatants were harvested and subjected to the enzyme-linked immunosorbent assay (ELISA) of IFN-g, IL-4, IL-10 and IL-17. Treatment conditions: control (medium alone), nicotine alone (Nic), CD3/CD28 stimulation alone, CD3/CD28 plus Nic, and CD3/CD28 plus Nic and mecamylamine (Mec). þ Indicates Po0.05 compared with control, * indicates Po0.05 compared with CD3/CD28 stimulation alone and finding of a3, a5, a7, b2 and b4 subunits in immature T cells vs a2, a5 and a7 in mature T cells. 29 Reportedly, the nicotinic stimulation selectively induced proliferation of only mature subpopulation of murine thymocytes. 30 The factors that can affect both the repertoire and the ligandbinding affinities of cholinergic receptors include the dose and duration of exposure to an agonist, antigen stimulation, cytokine milieu and a large variety of other non-immunological and immunological stimulations. [2] [3] [4] 10, 22, [31] [32] [33] [34] [35] [36] [37] [38] This helps in explaining the discrepancy of our in vitro findings with the previous report that nicotine treatment of mice with experimental autoimmune encephalomyelitis fosters a shift from Th1 toward Th2 or Th3 responses. 38 In that study, however, the reduction in secreted IFN-g was most marked in CD8 compared with CD4 cells.
Our findings indicate that the cholinergic networks of T cells can adjust to environmental changes. We observed that TCR stimulation affected the ACh receptor profile of both CD4 and CD8 cells, eliciting both common and unique changes. Upon activation, both CD4 and CD8 cells started to express a4 and a7 nAChRs, and showed unregulated expression of a5, b4, M 4 and M 5 , and downregulated expression of a9, b2 and M 3 . The activated CD4 cells uniquely overexpressed a10, whereas activated CD8 cells overexpressed a2 receptor. The differences in relative changes of the mRNA and protein levels of the same molecule may be also attributed to known differences in their half lives or stability. 39 In the past, it has been shown that stimulation of T cells with PHA alters the expression of nAChR subunits. 5 This phenomenon is not unique to T cells, as various neuronal and non-neuronal cells normally change their cholinergic profile during differentiation and upon environmental stimulation. [40] [41] [42] [43] [44] [45] Interestingly, although activated CD4 T cells expressed a7 nAChR (Figures 2a and b) , neither Th1, Th2 or Th17 cells derived from the CD4 þ CD62L þ CD4 T cells showed any detectable levels of this receptor. Perhaps, it was expressed by CD4 þ CD62L À or another subpopulation of CD4 cells negatively selected by MACS sorting. Thus, changes in the profiles of nAChRs and mAChRs on the plasma membrane of T lymphocytes resemble a paradigm established for the cluster of differentiation markers.
Our results indicate that autocrine/paracrine ACh exhibits a dichotomous regulation of T-cell polarization, because activation of nAChRs in naïve CD4 T cells upregulated Th1 and inhibited Th17 cytokine production, whereas stimulation of mAChRs upregulated secretion of both Th2 and Th17 cytokines. These observations are in keeping with earlier reports about cholinergic regulation of CD4 T-cell differentiation toward Th1, Th2 and Th17 lineages. Similar to murine T cells (Figure 4) , human T cells also respond to nicotine by an increased production of the Th1 cytokine INF-g without altering the Th2 cytokine IL-4. 46 Furthermore, it has been reported that nicotine induces a sevenfold increase in the secretion of Th1 cytokine IL-12 by Figure 4 The muscarinic effects on cytokine production by CD4 þ CD62L þ T cells. The enriched naïve CD4 þ CD62L þ T cells were cultured without any additions (control) or stimulated with anti-CD3 and anti-CD28 in the presence or absence of the mAChR agonist muscarine, 1 mM, ± the antagonist atropine, 100 mM, as detailed in Materials and methods. After 5 days in the culture, the supernatants were harvested and subjected to the ELISA of IFN-g, IL-4, IL-10 and IL-17. Treatment conditions: control (medium alone), muscarine (Mus) alone, CD3/CD28 stimulation alone, CD3/CD28 plus Mus and CD3/CD28 plus Mus and atropine (Atr). þ Indicates Po0.05 compared with control, * indicates Po0.05 compared with CD3/CD28 stimulation alone and # indicates Po0.05 compared with CD3/CD28 plus Mus.
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J Qian et al dendritic cells 25 and suppresses Th17 response. 22 Of note, exposure of human lamina propria T cells to nicotine upregulates expression of the Th1-specific transcription factor T-bet without affecting the Th2-specific transcription factor GATA-3, thus skewing the immune response toward Th1-dominant pattern. 46 Taken together, these findings provide a solid evidence that signaling along the nicotinic arm of the ACh regulatory axis of murine and human T cells augments Th1 polarization, whereas the muscarinic arm facilitates Th2 and Th17 differentiation. As muscarine stimulated IL-10 production in our study, the T-cell mAChRs may also be coupled to augmentation of the iTreg development.
In conclusion, our results vividly demonstrated plasticity and function of the ACh regulatory axis in murine T cells that can be simultaneously stimulated by autocrine/paracrine ACh through two classes of cellsurface receptors, nAChRs and mAChRs. This may be required to synchronize and balance ionic and metabolic events in a single lymphocyte. The fact that activation of CD4 and CD8 cells through TCR/CD3 cross-linking produced distinct changes in the nAChR and mAChR repertoires, taking together with previous reports that nicotinic and muscarinic stimulations of T cells alter their TCR-dependent activities, 47, 48 and that CD3z and a7 nAChR can be co-immunoprecipitated, 49 suggests strongly that ACh signaling is essential for T-cell activation. Hence, alterations within the T-cell ACh regulatory axis may provide for a fine tuning of the T cells to changing environment. This novel mechanism may be exploited for developing novel pharmacological methods of selective immunocorrection using cholinergic drugs.
Materials and methods
Murine T-cell isolation
The C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). All mice were bred under specific pathogen-free conditions and were used between 8 and 12 weeks of age. The splenic CD4 and CD8 T cells were separated by negative selection via MACS sorting (Miltenyi Biotec, Auburn, CA, USA) following the protocol provided by the manufacturer. The cocktail of antibodies to CD8a, CD11b, CD11c, CD19, CD45R (B220), CD49b (DX5), CD105, MHC class II and Ter-119 was used to label and deplete non-CD4 T cells, whereas the cocktail of antibodies to CD4, CD11b, CD11c, CD19, CD45R (B220), CD49b (DX5), CD105, MHC class II and Ter-119 was used to label and deplete non-CD8 T cells. In all experiments, the purity exceeded 95%, as determined by FCM.
TCR stimulation
To stimulate T cells via the TCR/CD3 complex, 200 ml of 2 Â 10 6 cells per ml was seeded in each well of the 96-well U-bottomed tissue culture plates (BD Falcon, BD Biosciences, San Jose, CA, USA) coated for 2 h at 37 1C with 10 mg ml À1 of anti-mouse CD3 (clone 145-2C11) and 4.0 mg ml À1 of anti-mouse CD28 (clone 37.51) antibodies (both from BD Biosciences), and cultured for 5 days in 5% CO 2 humid atmosphere at 37 1C. The cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum, 0.05 mM 2-mercaptoethanol, 10 mM HEPES buffer, 100 U ml À1 penicillin, 100 mg ml À1 streptomycin, 2 mM L-glutamine and 1 mM sodium pyruvate (all from Invitrogen, Carlsbad, CA, USA).
þ naïve T cells were enriched by using the CD4 þ CD62L þ T cell isolation kit II and MACS sorting (Miltenyi Biotec). To derive Th1/Th2/Th17 cells, naïve CD4 T cells were cultured in the Th1-conditioned medium containing 20 mg ml À1 of anti-IL-4 (clone 11B11; BD Biosciences) and 20 ng ml of anti-CD3 and 6 mg ml À1 of anti-CD28 antibodies, and cultured at the concentration of 2 Â 10 6 cells per ml in the presence of 10 ng ml À1 of human IL-2 for 5 days. 50 All recombinant cytokines used in experiments were purchased from PeproTech (Rocky Hill, NJ, USA). The purity of CD4 þ CD62 L þ T cells before TCR stimulation was about Figure 5 The nAChR subunits and mAChR subtypes expressed in Th1, Th2 and Th17 cells. The naïve CD4 þ CD62L þ T cells were cultured in the conditioned media for polarization toward Th1, Th2 or Th17 lineages, as detailed in Materials and methods, and the polarized cells were analyzed by qPCR (a) and ICW (b) for the relative amounts of mRNA and proteins, respectively, of the a1, a2, a3, a4, a5, a6, a7, a9, a10, b1, b2, b3 and b4 nAChR subunits, and M1, M2, M3, M4 and M5 mAChR subtypes. Results are expressed as fold of receptor mRNA or protein in polarized CD4 T cells compared with that in naïve CD4 þ CD62L þ T cells (control), taken as 1. * Indicates Po0.05 compared with control.
93%. After differentiation, the purity of CD4 cells reached 100% (Supplementary Figure 1) .
Real-time quantitative PCR
Total RNA was isolated using the RNeasy mini kit (Qiagen, Valencia, CA, USA), treated with DNase (RNase-free DNase Set; Qiagen) and concentrated by RNeasy MinElute cleanup kit (Qiagen). In all, 2 mg of total RNA was reverse transcribed into 20 ml complementary DNA using the high capacity complementary DNA reverse transcription kit (Applied Biosystems, Carlsbad, CA, USA). Quantitative PCR was performed in duplicate using the Applied Biosystems 7500 instrument. Because of the high homology of ACh receptors and evidence of alternatively spliced isoforms, only conserved regions of all mRNA variants of target genes were amplified using the inventoried TaqMan gene expression assays (Applied Biosystems) for the nAChR subunits a1 (Mm00431627_m1), a2
(Mm00532602_m1) and b4 (Mm00804952_m1), and the mAChR subtypes M 1 (Mm00432509_s1), M 2 (Mm01167087_ m1), M 3 (Mm00446300_s1), M 4 (Mm00432514_s1) and M 5 (Mm01701883_s1). In all, 1 ml of complementary DNA was used per 20 ml of amplification reaction. Ubiquitin C (Mm01201237_m1) was amplified as an endogenous reference gene. As positive controls, we used the murine muscle and brain PCR ready first strand complementary DNAs (BioChain Institute Inc., Hayward, CA, USA). To control for the contamination of DNase-treated samples with residual genomic DNA, the reverse transcription step was omitted. The relative expression level was calculated by DDCt method with a Sequence Detection Software version 1.2.3 (Applied Biosystems).
In-cell western
The in-cell western, a high throughput quantitative assay of cellular proteins, was performed in situ, as described by us in detail elsewhere, 5 using the reagents and the Odyssey Infrared Imaging System from LI-COR Biosciences (Lincoln, NE, USA). The freshly isolated or TCR/ CD3 cross-linking-activated CD4 and CD8 T cells were seeded into 96-well U plates at a concentration of 2 Â 10 5 cells per well, fixed with 4% PFA and permeabilized with 0.1% Triton solution. The cells were incubated with the Odyssey blocking buffer for 1.5 h, treated overnight at 4 1C with the primary rabbit antibodies to individual ACh receptors, washed and stained for 1 h at room temperature with a secondary LI-COR IRDye 800CW goat anti-rabbit antibody, diluted 1:800. A combination of Sapphire700 (1:1000, LI-COR Biosciences) and DRAQ (1:10000, Cell Signaling, Danvers, MA, USA) was used to normalize for the cell number per well. The antibodies to a3, a4, a5, a7, b2, b3 and b4 nAChR subunits, and M 1 -M 5 mAChR subtypes were from R&D Antibodies (North Las Vegas, NV, USA), a1 and a6 nAChRs from Abcam (Cambridge, MA, USA), a2 and a9 from Genway (San Diego, CA, USA), and anti-b1 antibody was from Protein Tech Group (Chicago, IL, USA). The antibodies were diluted 1:100-1:200 in the Odyssey blocking buffer according to manufacturer's recommendations. All antibodies recognized their relevant receptor protein at the appropriate molecular weight (Supplementary Figure 2) . Although several antibodies produced some background staining, it did not affect the results of in-cell western experiments expressed as relative values (fold of control).
Cytokine assays
The nAChRs were stimulated with the agonist nicotine, 1 mM, and inhibited with the antagonist mecamylamine, 100 mM, whereas the mAChRs were activated with muscarine, 1 mM, and inhibited with atropine, 100 mM (all from Sigma-Aldrich Corp. St Louis, MO, USA). The freshly prepared solutions of test drugs were added to CD4 þ CD62L þ T cells and the cultures were incubated with or without TCR/CD3 complex stimulation for 5 days. We have counted cell numbers and checked the cell viability by FCM using SSC/FSC before and after nicotine exposure, and found no difference (Supplementary Figure 3) . The cytokines IFN-g, IL-4, IL-10 and IL-17 were assayed by antibody sandwich enzyme-linked immunosorbent assay in cell culture supernatants using the mouse ELISA Ready-SET-Go kits (eBioscience, San Diego, CA, USA) according to the manufacturer's instruction.
Statistical analysis
Each experiment was performed three times and each time it included cells isolated from four mice. The results were expressed as means±s.d. Statistical significance was determined using Student's t-test. The differences were deemed significant when the calculated P-value was o0.05.
